Health state utilities associated with treatment for transfusion-dependent β-thalassemia

ConclusionsUtilities followed expected patterns, with logical differences between treatment options for TDT and substantially greater utility for transfusion independence than for ongoing treatment involving transfusion and chelation. These utilities may be useful in cost-utility models estimating the value of treatments for TDT.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research